Published in TB and Outbreaks Week, November 16th, 2004
"The PEARLS study prospectively monitored selected nosocomial pathogens from 38 centers in 13 European, three Middle Eastern countries and South Africa during 2001-2002.
"Extended spectrum P-lactamase (ESBL) production rates among Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp. were 5.4% (142/2609), 18.2% (401/2206) and 8.8% (204/2328), respectively, for all study sites," researchers in the United States report.
"The overall ESBL production rate for the combined Enterobacteriaceae was 10.5% (747/7143), highest...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.